weight loss information
|
Clinical Trials of Xenical Obesity Drug for Weight ReductionXenical Weight Loss Drugs - StudyQuestions
About Obesity Medications
|
| The 12 month study of 430 overweight men and women (Body Mass Index of 30-43), was designed to assess the effectiveness of Xenical in patients who are responsive to treatment. Patients who achieved five per cent (approximately 5kg) weight loss after three months and maintained this after a further three months of Xenical treatment, were followed for one year. During this time weight loss and other health improvements, such as reductions in blood pressure, were assessed. |
The greatest weight loss was seen in the first four weeks of treatment, with an average weight loss of 4.1 kg.
70 percent of patients who entered the study achieved and maintained at least 5 percent weight loss of 6 months.
The mean weight loss after one year was 11.6 kg.
One in two patients who completed the study lost more than 10 per cent of their initial weight, and over eight in 10 people lost more than five per cent - an amount of weight loss shown to clinically improve the health and well-being of overweight people.
Xenical is the most extensively studied pharmacological weight management treatment to date, with over 30,000 overweight or obese patients participating in clinical trials. It is an effective therapy that not only helps patients lose weight, but also helps them maintain their weight loss. Since the launch of Xenical in 1998 there have been more than 13.2 million patient treatments world-wide.
com